Enimmune Corporation (TPEX:6564)
Taiwan · Delayed Price · Currency is TWD 16.45
+0.20 (1.23%)
Oct 8, 2026, 2:35 PM CST
Enimmune Market Cap
Enimmune has a market cap or net worth of 1.19 billion as of October 9, 2026. It is the 32,593rd most valuable company in the world and the 1,961st biggest in Taiwan. Its market cap has decreased by 21.29% in one year.
Market Cap
1.19B
Enterprise Value
1.17B
Revenue
53.45M
Global Rank
Country Rank
#1,961 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2018, Enimmune's market cap has decreased from 1.33B to 1.19B, a decrease of -10.67%. That is a compound annual growth rate of -1.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.19B | -20.15% |
| Dec 31, 2025 | 1.49B | -17.27% |
| Dec 31, 2024 | 1.80B | -27.21% |
| Dec 29, 2023 | 2.47B | -38.63% |
| Dec 30, 2022 | 4.02B | 69.85% |
| Dec 30, 2021 | 2.37B | -11.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.42B |
| Abnova (Taiwan) | 1.37B |
| NeoCore Technology | 1.24B |
| Holy Stone Healthcare | 1.18B |
| Bio Preventive Medicine | 1.18B |
| GeneReach Biotechnology | 1.13B |
| LabTurbo Biotech | 1.11B |
| BiOptic | 1.03B |